Anti-inflammatory properties of enamel matrix derivative in human blood

Journal of Periodontal Research

Volumn 41, Issue 3, 2006, Pages 208-213

  Myhre, A E ^a,e   Lyngstadaas, S P ^b   Dahle, M K ^a   Stuestol J F ^a   Foster, S J ^c   Thiemermann, C ^d   Lilleaasen, P ^a   Wang, J E ^a   Aasen, A O ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Amelogenin; Cyclic AMP; Emdogain; Inflammation

Indexed keywords

8 ((4 CHLOROPHENYL)THIO)CYCLIC 3',5' AMP; 8-((4-CHLOROPHENYL)THIO)CYCLIC-3',5'-AMP; ANTIINFLAMMATORY AGENT; CYCLIC AMP; DRUG DERIVATIVE; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; ENZYME INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; NUCLEOTIDE; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI; HUMAN; MONONUCLEAR CELL; STAPHYLOCOCCUS AUREUS; SWINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYCLIC AMP; DENTAL ENAMEL PROTEINS; ENZYME INHIBITORS; ESCHERICHIA COLI; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; PEPTIDOGLYCAN; STAPHYLOCOCCUS AUREUS; SWINE; THIONUCLEOTIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646523812     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2005.00863.x     Document Type: Article

References (38)

1. Sculean A Windisch P Keglevich T Fabi B Lundgren E Lyngstadaas SP Presence of an enamel matrix derivative on human teeth following periodontal surgery Clin Oral Invest 2002 6 183 187
2. Wennstrom JL Lindhe J Some effects of enamel matrix proteins on wound healing in the dento-gingival region J Clin Periodontol 2002 29 9 14
3. Hoang AM Oates TW Cochran DL In vitro wound healing responses to enamel matrix derivative J Periodontol 2000 71 1270 1277
4. Lyngstadaas SP Ellingsen JE Spahr A Slaby I. Inducing bone growth using extracellular matrix proteins In Ellingsen JE Lyngstadaas SP eds The Bio-Implant Interface; Improving Biomaterials and Tissue Reactions Boca Raton CRC Press 2003 261 281
5. Lyngstadaas SP Lundberg E Ekdahl H Andersson C Gestrelius S Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative J Clin Periodontol 2001 28 181 188
6. van der Pauw MT Van den Bos T Everts V Beertsen W Enamel matrix-derived protein stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor beta1 release of periodontal ligament and gingival fibroblasts J Periodontol 2000 71 31 43
7. Yuan K Chen CL Lin MT Enamel matrix derivative exhibits angiogenic effect in vitro and in a murine model J Clin Periodontol 2003 30 732 738
8. Hoffmann E Ditrich-Breiholz O Holtmann H Kracht M Multiple control of interleukin-8 gene expression J Leukoc Biol 2002 72 847 855
9. de Waal RM Abrams J Bennett B Figdor CG de Vries JE Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes J Exp Med 1991 174 1209 1220
10. Fiorentino DF Zlotnik A Mosmann TR Howard M O'Garra A IL-10 inhibits cytokine production by activated macrophages J Immunol 1991 147 3815 3822
11. Brandtzaeg P Osnes L Ovstebo R Joo GB Westvik AB Kierulf P Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes J Exp Med 1996 184 51 60
12. Angus DC Linde-Zwirble WT Lidicker J Clermont G Carcillo J Pinsky MR Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 2001 29 1303 1310
13. Foster SJ Analysis of the autolysins of Bacillus subtilis 168 during vegetative growth and differentiation by using renaturing polyacrylamide gel electrophoresis J Bacteriol 1992 174 464 470
14. Wang JE Solberg R Okkenhaug C Jorgensen PF Krohn CD Aasen AO Cytokine modulation in experimental endotoxemia: characterization of an ex vivo whole blood model Eur Surg Res 2000 32 65 73
15. Petinaki E Nikolopoulos S Castanas E Low stimulation of peripheral lymphocytes, following in vitro application of Emdogain J Clin Periodontol 1998 25 715 720
16. Nikolopoulos S Peteinaki E Castanas E Immunologic effects of emdogain in humans: one-year results Int J Periodont Rest 2002 22 269 277
17. Aasen AO Rishovd AL Stadaas JO Role of endotoxin and proteases in multiple organ failure (MOF) Prog Clin Biol Res 1989 308 315 322
18. Borovikova LV Ivanova S Zhang M et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin Nature 2000 405 458 462
19. Wang JE Dahle MK Yndestad A et al. Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat Crit Care Med 2004 32 546 552
20. Casey LC Balk RA Bone RC Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome Ann Intern Med 1993 119 771 778
21. Michie HR Manogue KR Spriggs DR et al. Detection of circulating tumor necrosis factor after endotoxin administration N Engl J Med 1988 318 1481 1486
22. Baggiolini M Clark-Lewis I Interleukin-8, a chemotactic and inflammatory cytokine FEBS Lett 1992 307 97 101
23. Reinhart K Karzai W Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned Crit Care Med 2001 29 S121 S125
24. Baue AE Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets? Arch Surg 1997 132 703 707
25. Hatakeyama J Sreenath T Hatakeyama Y et al. The receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenic pathway is elevated in amelogenin-null mice J Biol Chem 2003 278 35743 35748
26. Lee ZH Kim HH Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts Biochem Biophys Res Commun 2003 305 211 214
27. Badger AM Olivera DL Esser KM Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock Circ Shock 1994 44 188 195
28. van der Poll T Jansen J Endert E Sauerwein HP van Deventer SJ Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood Infect Immun 1994 62 2046 2050
29. Bernardin G Kisoka RL Delporte C Robberecht P Vincent JL Impairment of beta-adrenergic signaling in healthy peripheral blood mononuclear cells exposed to serum from patients with septic shock: involvement of the inhibitory pathway of adenylyl cyclase stimulation Shock 2003 19 108 112
30. Chong YH Shin SA Lee HJ Kang JH Suh YH Molecular mechanisms underlying cyclic AMP inhibition of macrophage dependent TNF-alpha production and neurotoxicity in response to amyloidogenic C-terminal fragment of Alzheimer's amyloid precursor protein J Neuroimmunol 2002 133 160 174
31. Spengler RN Spengler ML Lincoln P Remick DG Strieter RM Kunkel SL Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression Infect Immun 1989 57 2837 2841
32. Torgersen KM Vang T Abrahamsen H Yaqub S Tasken K Molecular mechanisms for protein kinase A-mediated modulation of immune function Cell Signal 2002 14 1 9
33. Nakamura A Imaizumi A Yanagawa Y Kohsaka T Johns EJ beta(2)-Adrenoceptor activation attenuates endotoxin-induced acute renal failure J Am Soc Nephrol 2004 15 316 325
34. Yanase T Enzan K Mitsuhata H Horiguchi T Dibutyryl cAMP improves systemic vasoconstriction caused by endotoxin in dogs Shock 1996 5 284 288
35. Simmer JP Alternative splicing of amelogenins Connect Tissue Res 1995 32 131 136
36. Tan J Leung W Moradian-Oldak J Zeichner-David M Fincham AG The pH dependent amelogenin solubility and its biological significance Connect Tissue Res 1998 38 215 221
37. Veis A Amelogenin gene splice products: potential signaling molecules Cell Mol Life Sci 2003 60 38 55
38. Veis A Tompkins K Alvares K et al. Specific amelogenin gene splice products have signaling effects on cells in culture and in implants in vivo J Biol Chem 2000 275 41263 41272